Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10961-6. doi: 10.1073/pnas.1005641107. Epub 2010 Jun 1.

Abstract

Natural killer-22 (NK-22) cells are a human NK cell subset situated in mucosal-associated lymphoid tissues that specialize in IL-22 secretion in response to IL-23. Here we investigated the cytokine requirements for NK-22 cell expansion. IL-7 maintained the survival of NK-22 cells and IL-22 production in response to IL-23 but was insufficient to induce robust expansion. Proliferation of NK-22 cells was increased markedly by adding either IL-1beta or IL-2 to IL-7 and was even stronger in the presence of IL-1beta plus IL-2. In contrast to IL-7, continuous culture in IL-1beta and IL-2 modified NK-22 cytokine profiles. IL-1beta promoted constitutive IL-22 secretion rather than acute IL-22 production in response to IL-23 and induced IL-17 in some cells. IL-2 reduced secretion of IL-22 and IL-17, increasing production of IFN-gamma and leukemia inhibitory factor. Functional deviation toward IFN-gamma production also was induced by continuous culture in IL-23. These results demonstrate the functional plasticity of NK-22 cells, which may allow flexible responses to different pathogens. Finally, we found that NK-22 cells released the B-cell survival factor, B-cell activating factor belonging to the TNF family (BAFF), suggesting a potential role of NK-22 cells in promoting B-cell-mediated mucosal immunity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • B-Cell Activating Factor / biosynthesis
  • Base Sequence
  • Cell Proliferation / drug effects
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • DNA Primers / genetics
  • Humans
  • In Vitro Techniques
  • Interferon-gamma / biosynthesis
  • Interleukin-1beta / pharmacology*
  • Interleukin-2 / pharmacology*
  • Interleukin-22
  • Interleukin-23 Subunit p19 / pharmacology
  • Interleukin-7 / pharmacology*
  • Interleukins / biosynthesis*
  • Killer Cells, Natural / classification*
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Leukemia Inhibitory Factor / biosynthesis
  • Lymphocyte Subsets / classification*
  • Lymphocyte Subsets / cytology
  • Lymphocyte Subsets / drug effects
  • Lymphocyte Subsets / immunology*
  • Palatine Tonsil / cytology
  • Palatine Tonsil / immunology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Recombinant Proteins / pharmacology

Substances

  • B-Cell Activating Factor
  • Cytokines
  • DNA Primers
  • IL2 protein, human
  • IL23A protein, human
  • IL7 protein, human
  • Interleukin-1beta
  • Interleukin-2
  • Interleukin-23 Subunit p19
  • Interleukin-7
  • Interleukins
  • LIF protein, human
  • Leukemia Inhibitory Factor
  • RNA, Messenger
  • Recombinant Proteins
  • TNFSF13B protein, human
  • Interferon-gamma